Algernon Announces Enrollment of First U.S. Patient in Multinational Phase 2b/3 Human Study of Ifenprodil for Treatment of COVID-19

VANCOUVER, British Columbia, Aug. 13, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.…

Revive Therapeutics Advancing Drug Delivery Technology for Psychedelics

Developed Prototypes of Orally Dissolvable Thin Film For Psilocybin TORONTO, Aug. 11,…